Yi-Guang Chen

Dr. Yi-Guang Chen


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AKAchia Khatun
Achia Khatun
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
RZRyan Zander
Ryan Zander
DSDavid M. Schauder
David M. Schauder
JSJeremy P. Snook
Jeremy P. Snook
WCWeiguo Cui
Weiguo Cui
Tracking how individual naive T cells from a natural TCR repertoire clonally expand, differentiate, and make lineage choices in response to an infection has not previously been possible. Here, using single-cell sequencing technology to identify clones by their unique TCR sequences, we were able to trace the clonal expansion, differentiation trajectory, and lineage commitment of individual virus-specific CD4 T cells during an acute lymphocytic choriomeningitis virus (LCMV) infection. Notably, we found previously unappreciated clonal diversity and cellular heterogeneity among virus-specific helper T cells. Interestingly, although most naive CD4 T cells gave rise to multiple lineages at the clonal level, ∼28% of naive cells exhibited a preferred lineage choice toward either Th1 or TFH cells. Mechanistically, we found that TCR structure, in particular the CDR3 motif of the TCR α chain, skewed lineage decisions toward the TFH cell fate.

1 December 2019 in Cell Reports
Verified
Journal Article
Open access
ACAshley E. Ciecko
Ashley E. Ciecko
BFBardees Foda
Bardees Foda
JBJennifer Y. Barr
Jennifer Y. Barr
SRSheela Ramanathan
Sheela Ramanathan
MAMark A. Atkinson
Mark A. Atkinson
YCYi-Guang Chen
Yi-Guang Chen
Human genetic studies implicate interleukin-27 (IL-27) in the pathogenesis of type 1 diabetes (T1D), but the underlying mechanisms remain largely unexplored. To further define the role of IL-27 in T1D, we generated non-obese diabetic (NOD) mice deficient in IL-27 or IL-27Rα. In contrast to wild-type NOD mice, both NOD.Il27-/- and NOD.Il27ra-/- strains are completely resistant to T1D. IL-27 from myeloid cells and IL-27 signaling in T cells are critical for T1D development. IL-27 directly alters the balance of regulatory T cells (Tregs) and T helper 1 (Th1) cells in pancreatic islets, which in turn modulates the diabetogenic activity of CD8 T cells. IL-27 also directly enhances the effector function of CD8 T cells within pancreatic islets. In addition to T1D, IL-27 signaling in T cells is also required for lacrimal and salivary gland inflammation in NOD mice. Our study reveals that IL-27 contributes to autoimmunity in NOD mice through multiple mechanisms and provides substantial evidence to support its pathogenic role in human T1D.

15 May 2024 in Immunity
Verified
Journal Article
Open access
NSNeetu Srivastava
Neetu Srivastava
HHHao Hu
Hao Hu
OPOrion J. Peterson
Orion J. Peterson
AVAnthony N. Vomund
Anthony N. Vomund
MSMarta Stremska
Marta Stremska
XWXiaoxiao Wan
Xiaoxiao Wan
The pancreatic islet microenvironment is highly oxidative, rendering β cells vulnerable to autoinflammatory insults. Here, we examined the role of islet resident macrophages in the autoimmune attack that initiates type 1 diabetes. Islet macrophages highly expressed CXCL16, a chemokine and scavenger receptor for oxidized low-density lipoproteins (OxLDLs), regardless of autoimmune predisposition. Deletion of Cxcl16 in nonobese diabetic (NOD) mice suppressed the development of autoimmune diabetes. Mechanistically, Cxcl16 deficiency impaired clearance of OxLDL by islet macrophages, leading to OxLDL accumulation in pancreatic islets and a substantial reduction in intra-islet transitory (Texint) CD8+ T cells displaying proliferative and effector signatures. Texint cells were vulnerable to oxidative stress and diminished by ferroptosis; PD-1 blockade rescued this population and reversed diabetes resistance in NOD.Cxcl16-/- mice. Thus, OxLDL scavenging in pancreatic islets inadvertently promotes differentiation of pathogenic CD8+ T cells, presenting a paradigm wherein tissue homeostasis processes can facilitate autoimmune pathogenesis in predisposed individuals.

23 January 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
SASantiago Alvarez-Argote
Santiago Alvarez-Argote
SPSamantha J. Paddock
Samantha J. Paddock
MFMichael A. Flinn
Michael A. Flinn
CMCaelan W. Moreno
Caelan W. Moreno
MKMakenna C. Knas
Makenna C. Knas
COCaitlin O'Meara
Caitlin O'Meara
There is great interest in identifying signaling pathways that promote cardiac repair after myocardial infarction (MI). Prior studies suggest a beneficial role for IL-13 signaling in neonatal heart regeneration; however, the cell types mediating cardiac regeneration and the extent of IL-13 signaling in the adult heart after injury are unknown. We identified an abundant source of IL-13 and the related cytokine, IL-4, in neonatal cardiac type 2 innate lymphoid cells, but this phenomenon declined precipitously in adult hearts. Moreover, IL-13 receptor deletion in macrophages impaired cardiac function and resulted in larger scars early after neonatal MI. By using a combination of recombinant IL-13 administration and cell-specific IL-13 receptor genetic deletion models, we found that IL-13 signaling specifically to macrophages mediated cardiac functional recovery after MI in adult mice. Single transcriptomics revealed a subpopulation of cardiac macrophages in response to IL-13 administration. These IL-13–induced macrophages were highly efferocytotic and were identified by high IL-1R2 expression. Collectively, we elucidated a strongly proreparative role for IL-13 signaling directly to macrophages following cardiac injury. While this pathway is active in proregenerative neonatal stages, reactivation of macrophage IL-13 signaling is required to promote cardiac functional recovery in adults.

10 September 2021 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ACAshley E Ciecko
Ashley E Ciecko
DSDavid M. Schauder
David M. Schauder
BFBardees Foda
Bardees Foda
GPGalina Petrova
Galina Petrova
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
YCYi-Guang Chen
Yi-Guang Chen
In type 1 diabetes (T1D) autoreactive CD8 T cells infiltrate pancreatic islets and destroy insulin-producing β cells. Progression to T1D onset is a chronic process, which suggests that the effector activity of β-cell autoreactive CD8 T cells needs to be maintained throughout the course of disease development. The mechanism that sustains diabetogenic CD8 T cell effectors during the course of T1D progression has not been completely defined. Here we used single-cell RNA sequencing to gain further insight into the phenotypic complexity of islet-infiltrating CD8 T cells in NOD mice. We identified two functionally distinct subsets of activated CD8 T cells, CD44highTCF1+CXCR6− and CD44highTCF1−CXCR6+, in islets of prediabetic NOD mice. Compared with CD44highTCF1+CXCR6− CD8 T cells, the CD44highTCF1−CXCR6+ subset expressed higher levels of inhibitory and cytotoxic molecules and was more prone to apoptosis. Adoptive cell transfer experiments revealed that CD44highTCF1+CXCR6− CD8 T cells, through continuous generation of the CD44highTCF1−CXCR6+ subset, were more capable than the latter population to promote insulitis and the development of T1D. We further showed that direct IL-27 signaling in CD8 T cells promoted the generation of terminal effectors from the CD44highTCF1+CXCR6− population. These results indicate that islet CD44highTCF1+CXCR6− CD8 T cells are a progenitor-like subset with self-renewing capacity, and, under an IL-27–controlled mechanism, they differentiate into the CD44highTCF1−CXCR6+ terminal effector population. Our study provides new insight into the sustainability of the CD8 T cell response in the pathogenesis of T1D.

15 May 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MFMatthew H. Forsberg
Matthew H. Forsberg
ACAshley E Ciecko
Ashley E Ciecko
KBKyle J. Bednar
Kyle J. Bednar
AIArata Itoh
Arata Itoh
KKKritika Kachapati
Kritika Kachapati
YCYi-Guang Chen
Yi-Guang Chen
We previously reported that CD137 (encoded by Tnfrsf9) deficiency suppressed type 1 diabetes (T1D) progression in NOD mice. We also demonstrated that soluble CD137 produced by regulatory T cells contributed to their autoimmune-suppressive function in this model. These results suggest that CD137 can either promote or suppress T1D development in NOD mice depending on where it is expressed. In this study, we show that NOD.Tnfrsf9−/− CD8 T cells had significantly reduced diabetogenic capacity, whereas absence of CD137 in non-T and non-B cells had a limited impact on T1D progression. In contrast, NOD.Tnfrsf9−/− CD4 T cells highly promoted T1D development. We further demonstrated that CD137 was important for the accumulation of β cell–autoreactive CD8 T cells but was dispensable for their activation in pancreatic lymph nodes. The frequency of islet-infiltrating CD8 T cells was reduced in NOD.Tnfrsf9−/− mice in part because of their decreased proliferation. Furthermore, CD137 deficiency did not suppress T1D development in NOD mice expressing the transgenic NY8.3 CD8 TCR. This suggests that increased precursor frequency of β cell–autoreactive CD8 T cells in NY8.3 mice obviated a role for CD137 in diabetogenesis. Finally, blocking CD137–CD137 ligand interaction significantly delayed T1D onset in NOD mice. Collectively, our results indicate that one important diabetogenic function of CD137 is to promote the expansion and accumulation of β cell–autoreactive CD8 T cells, and in the absence of CD137 or its interaction with CD137 ligand, T1D progression is suppressed.